Stay updated on Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.

Latest updates to the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the lapse in government funding notice and the v3.4.1 revision were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide Notice about a lapse in government funding and updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated QC-related labels and policy text (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0). Removed the older wording variants (Last Update Submitted that met QC Criteria; No FEAR Act data) and the previous revision label (Revision: v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision label updated from v3.3.3 to v3.3.4. No substantive content or study details were changed.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter updates show Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.2 deployed; no visible changes to Study Details page content or user-facing behavior.SummaryDifference0.1%

Stay in the know with updates to Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Verubecestat Efficacy-Safety in Prodromal Alzheimer's Clinical Trial page.